Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL) : I. As2O3 exerts dose-dependent dual effects on APL cells

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Blood

Topics

Biology

Biochemistry

Chemistry

Immunology

Molecular Biology

Show all topics

DOI

10.1182/blood.v89.9.3345